BD to Present at Barclays 28th Annual Global Healthcare Conference
BD (NYSE: BDX) will present at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026 at 8:30 a.m. ET.
Rhea-AI Summary
BD (NYSE: BDX) will present at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026 at 8:30 a.m. ET. The presentation will be webcast live and a replay will be posted on BD's investor relations website, investors.bd.com.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BDX
On Feb 24, the first trading day after this news, BDX closed 1.00% below the previous close.
Data tracked by StockTitan Argus for the Feb 24 session.
Key Figures
- Conference presentation time
- 8:30 am Eastern Time
- Barclays 28th Annual Global Healthcare Conference on March 10, 2026
Historical Context
-
Named new executive vice president and general counsel joining leadership team.
-
Launched tender offers to repurchase up to $1.6B of senior notes.
-
Completed spin-off and cash-plus-stock combination of key businesses with Waters.
-
Waters closed combination with BD units via Reverse Morris Trust structure.
-
Reported Q1 FY2026 results and affirmed full-year New BD guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 8:30 am Eastern Time.
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media | Investors: |
Matt Marcus | Shawn Bevec SVP, Investor Relations |
View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-barclays-28th-annual-global-healthcare-conference-302694898.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.